Company name Ligand Pharmaceuticals Incorporated
Stock symbol LGND
Status Under Investigation

NEW YORK, January 29, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against Ligand Pharmaceuticals Incorporated (NYSE: LGND).  Our investigation concerns whether Ligand has violated the federal securities laws and/or engaged in other unlawful business practices.

On January 16, 2019, Citron Research published a report entitled “Pipeline Ligand Pipe Dream,” describing its observations of Ligand’s business.  The report detailed sources of future revenues by drug candidate, showing that roughly 60% of Ligand’s milestone payments stem from just two companies.  The report goes on to allege that some of Ligand’s partners have corporate addresses that are actually a private residence or UPS box, or do not occupy their supposed address.

On this news, Ligand’s share price fell by more than 16%, closing at $110.05 on January 16, 2019.

If you purchased or otherwise acquired Ligand shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

First name*

Last name*

City, state, ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 355-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.